Ownership history in Alphabet Inc. · 13 quarters on record
This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Tscan Therapeutics Inc. (TCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 1,077,080 | — | 0% | 0.08% | $2.0M | $1.82 |
| 2025 Q2 | UNCHANGED | 1,077,080 | — | 0% | 0.07% | $1.6M | $1.45 |
| 2025 Q1 | UNCHANGED | 1,077,080 | — | 0% | 0.09% | $1.5M | $1.38 |
| 2024 Q4 | UNCHANGED | 1,077,080 | — | 0% | 0.19% | $3.3M | $3.04 |
| 2024 Q3 | UNCHANGED | 1,077,080 | — | 0% | 0.29% | $5.4M | $4.98 |
| 2024 Q2 | UNCHANGED | 1,077,080 | — | 0% | 0.32% | $6.3M | $5.85 |
| 2024 Q1 | UNCHANGED | 1,077,080 | — | 0% | 0.34% | $8.6M | $7.94 |
| 2023 Q4 | UNCHANGED | 1,077,080 | — | 0% | 0.29% | $6.3M | $5.83 |
| 2023 Q3 | UNCHANGED | 1,077,080 | — | 0% | 0.18% | $2.8M | $2.56 |
| 2023 Q2 | UNCHANGED | 1,077,080 | — | 0% | 0.14% | $2.7M | $2.50 |
As of 2025 Q4 — sorted by position size